As of 2025-06-22, the Relative Valuation of Anika Therapeutics Inc (ANIK) is (53.82) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.59 USD, the upside of Anika Therapeutics Inc based on Relative Valuation is -608.2%.
The range of the Relative Valuation is (35.69) - (65.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 16.5x | 13.0x |
| Forward P/E multiples | 9.0x - 20.8x | 14.2x |
| Fair Price | (35.69) - (65.45) | (53.82) |
| Upside | -437.0% - -718.0% | -608.2% |
| Date | P/E |
| 2025-06-20 | -2.68 |
| 2025-06-18 | -2.81 |
| 2025-06-17 | -2.79 |
| 2025-06-16 | -2.81 |
| 2025-06-13 | -2.76 |
| 2025-06-12 | -2.85 |
| 2025-06-11 | -2.86 |
| 2025-06-10 | -2.92 |
| 2025-06-09 | -2.91 |
| 2025-06-06 | -2.87 |
| 2025-06-05 | -2.83 |
| 2025-06-04 | -2.94 |
| 2025-06-03 | -2.93 |
| 2025-06-02 | -2.89 |
| 2025-05-30 | -2.82 |
| 2025-05-29 | -2.85 |
| 2025-05-28 | -2.81 |
| 2025-05-27 | -2.82 |
| 2025-05-23 | -2.84 |
| 2025-05-22 | -2.97 |
| 2025-05-21 | -2.96 |
| 2025-05-20 | -3.02 |
| 2025-05-19 | -3.07 |
| 2025-05-16 | -3.08 |
| 2025-05-15 | -3.09 |
| 2025-05-14 | -2.86 |
| 2025-05-13 | -3.14 |
| 2025-05-12 | -2.99 |
| 2025-05-09 | -2.94 |
| 2025-05-08 | -3.73 |
| 2025-05-07 | -3.66 |
| 2025-05-06 | -3.56 |
| 2025-05-05 | -3.66 |
| 2025-05-02 | -3.75 |
| 2025-05-01 | -3.65 |
| 2025-04-30 | -3.67 |
| 2025-04-29 | -3.71 |
| 2025-04-28 | -3.67 |
| 2025-04-25 | -3.65 |
| 2025-04-24 | -3.63 |
| 2025-04-23 | -3.56 |
| 2025-04-22 | -3.59 |
| 2025-04-21 | -3.55 |
| 2025-04-17 | -3.54 |
| 2025-04-16 | -3.40 |
| 2025-04-15 | -3.47 |
| 2025-04-14 | -3.51 |
| 2025-04-11 | -3.45 |
| 2025-04-10 | -3.44 |
| 2025-04-09 | -3.53 |